Journal article
Protective Role for Itaconate During Inhaled Allergen Challenge
- Abstract:
- Background: Asthma is a chronic, heterogeneous disease characterised by airway remodelling, inflammation, and mucus production. Airway macrophages' functions are underpinned by changes in cellular metabolism. The TCA cycle‐derived metabolite itaconic acid (whose synthesis is mediated by aconitate decarboxylase) is a master regulator of macrophage function; however, its role during inhaled allergen challenge is not clear. The objective of this study was to define the role of itaconate during inhaled allergen challenge. Methods: Sputum metabolite levels were measured in participants with mild allergic asthma undergoing allergen inhalation challenge, and in a second cohort, baseline levels in mild, moderate, and severe asthmatics. Airway inflammation, lung function, and bronchoalveolar lavage metabolite levels were assessed in wild‐type and aconitate decarboxylase‐deficient mice, or in mice treated with inhaled itaconate. Results: Allergen inhalation in mild asthmatics led to a significant reduction in sputum itaconate. We found no difference in baseline sputum itaconate levels when comparing healthy controls to mild, moderate, or severe asthmatics. Continuous exposure to aeroallergen in wild type and aconitate decarboxylase‐deficient mice showed no change in disease phenotype after 48 h, 1, 3, or 5 weeks of allergen exposure. Treatment of house dust mite‐exposed mice with inhaled itaconate reduced airway inflammation. Conclusion: Levels of itaconate are altered after allergen challenge in mild asthmatics and in murine models of disease. Itaconate deficiency did not alter house dust mite‐induced pathology at any of the timepoints tested; however, inhaled itaconate ameliorated inflammatory responses to inhaled allergen.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 911.7KB, Terms of use)
-
- Publisher copy:
- 10.1111/all.70107
Authors
- Publisher:
- Wiley
- Journal:
- Allergy More from this journal
- Publication date:
- 2025-10-24
- Acceptance date:
- 2025-08-15
- DOI:
- EISSN:
-
1398-9995
- ISSN:
-
0105-4538
- Language:
-
English
- Keywords:
- Pubs id:
-
2302442
- Local pid:
-
pubs:2302442
- Source identifiers:
-
3408617
- Deposit date:
-
2025-10-25
- ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.
Terms of use
- Copyright date:
- 2025
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record